查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1729254

日本新一代定序市场报告（依定序类型、产品类型、技术、应用、最终使用者和地区）2025-2033

Japan Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年日本次世代定序市场规模达11亿美元。展望未来， IMARC Group预计到2033年市场规模将达到79亿美元，2025-2033年期间的成长率（CAGR）为22.4%。癌症和遗传疾病等慢性疾病的发生率不断上升，增加了对先进基因检测和定序技术的需求，从而推动了市场的发展。

次世代定序 (NGS) 是一种高通量、大规模平行 DNA 定序技术，可快速且经济高效地分析整个基因组、转录组和表观基因组。 NGS 可同时对数百万个 DNA 片段进行定序，从而可以在一次运行中产生大量资料。该技术促进了基因变异、基因表现模式的研究以及致病突变的识别，彻底改变了基因组学研究和生物医学应用。 NGS 具有多种应用，包括全基因组定序、外显子定序、RNA 定序和 ChIP 定序等。它大大加快了生物和医学研究的步伐，促进了个人化医疗、疾病诊断和复杂生物过程的理解的进步。然而，资料分析、储存和解释等挑战仍然存在，需要开发强大的生物资讯学工具和计算技术，以充分利用NGS在各个科学领域的潜力。

日本下一代定序市场趋势：

日本的下一代定序市场正在经历快速成长，主要受到几个关键因素的推动。首先，区域性慢性病盛行率的不断上升增加了对先进诊断工具的需求，推动了NGS技术的采用。因此，医疗保健提供者越来越多地将 NGS 整合到他们的临床实践中，旨在提供个人化治疗并改善患者的治疗效果。此外，基因组定序成本的大幅下降大大拓宽了NGS平台的可近性，从而促进了其在研究和临床环境中的广泛应用。此外，对精准医疗的日益关注以及基因组学在药物发现和开发中日益增长的重要性增强了对 NGS 的需求，促进了生物技术公司和研究机构之间的合作，以加快将基因组学见解转化为靶向疗法。此外，生物资讯学工具和资料分析技术的不断进步，促进了复杂基因组资料的解释，从而刺激了各个领域采用 NGS 技术，预计将在预测期内推动日本 NGS 市场的发展。

日本次世代定序市场细分：

定序类型洞察：

  • 全基因组定序
  • 标靶重测序
  • 全外显子定序
  • RNA定序
  • CHIP定序
  • 从头测序
  • 甲基化定序
  • 其他的

产品类型洞察：

  • 仪器
  • 试剂和耗材
  • 软体和服务

技术洞察：

  • 边合成边定序
  • 离子半导体定序
  • 单分子即时定序
  • 奈米孔定序
  • 其他的

应用程式洞察：

  • 生物标记与癌症
  • 药物研发与个人化医疗
  • 基因筛检
  • 诊断
  • 农业和动物研究
  • 其他的

最终用户洞察：

  • 学术机构与研究中心
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本下一代定序市场目前表现如何，未来几年将如何表现？
  • COVID-19 对日本下一代定序市场有何影响？
  • 根据定序类型，日本次世代定序市场是如何分類的？
  • 根据产品类型，日本次世代定序市场是如何分類的？
  • 日本次世代定序市场依技术分類的分布是怎么样的？
  • 日本下一代定序市场根据应用如何划分？
  • 根据最终用户，日本下一代定序市场是如何分類的？
  • 日本次世代定序市场的价值链分为哪些阶段？
  • 日本下一代定序的关键驱动因素和挑战是什么？
  • 日本次世代定序市场的结构是怎么样的？主要参与者是谁？
  • 日本新世代定序市场的竞争程度如何？

本报告回答的关键问题：

  • 日本下一代定序市场目前表现如何，未来几年将如何表现？
  • COVID-19 对日本下一代定序市场有何影响？
  • 根据定序类型，日本次世代定序市场是如何分類的？
  • 根据产品类型，日本次世代定序市场是如何分類的？
  • 日本次世代定序市场依技术分類的分布是怎么样的？
  • 日本下一代定序市场根据应用如何划分？
  • 根据最终用户，日本下一代定序市场是如何分類的？
  • 日本次世代定序市场的价值链分为哪些阶段？
  • 日本下一代定序的关键驱动因素和挑战是什么？
  • 日本次世代定序市场的结构是怎么样的？主要参与者是谁？
  • 日本新世代定序市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本次世代定序市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本新一代定序市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本新一代定序市场-细分：依定序类型

  • 全基因组定序
    • 概述
  • 标靶重测序
    • 概述
  • 全外显子定序
    • 概述
  • RNA定序
    • 概述
  • CHIP定序
    • 概述
  • 从头测序
    • 概述
  • 甲基化定序
    • 概述
  • 其他的

第七章：日本新一代定序市场-细分：依产品类型

  • 仪器
    • 概述
  • 试剂和耗材
    • 概述
  • 软体和服务
    • 概述

第八章：日本新一代定序市场-细分：依技术

  • 定序：透过合成
    • 概述
  • 离子半导体定序
    • 概述
  • 单分子即时定序
    • 概述
  • 奈米孔定序
    • 概述
  • 其他的

第九章：日本新一代定序市场-细分：依应用

  • 生物标记与癌症
    • 概述
  • 药物研发与个人化医疗
    • 概述
  • 基因筛检
    • 概述
  • 诊断
    • 概述
  • 农业和动物研究
    • 概述
  • 其他的

第十章：日本新一代定序市场-细分：依最终用户

  • 学术机构与研究中心
    • 概述
  • 医院和诊所
    • 概述
  • 製药和生物技术公司
    • 概述
  • 其他的

第 11 章：日本下一代定序市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 12 章：关键参与者简介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第十三章：日本下一代定序市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 14 章：附录

简介目录
Product Code: SR112025A19919

Japan next-generation sequencing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.9 Billion by 2033, exhibiting a growth rate (CAGR) of 22.4% during 2025-2033. The escalating incidence of chronic diseases, such as cancer and genetic disorders, which has increased the demand for advanced genetic testing and sequencing technologies, is driving the market.

Next-generation sequencing (NGS) is a high-throughput, massively parallel DNA sequencing technology that enables the rapid and cost-effective analysis of entire genomes, transcriptomes, and epigenomes. NGS simultaneously sequences millions of DNA fragments, allowing for the generation of large volumes of data in a single run. This technology has revolutionized genomics research and biomedical applications by facilitating the study of genetic variations, gene expression patterns, and the identification of disease-causing mutations. NGS has diverse applications, including whole-genome sequencing, exome sequencing, RNA sequencing, and ChIP sequencing, among others. It has significantly accelerated the pace of biological and medical research, contributing to advances in personalized medicine, disease diagnosis, and the understanding of complex biological processes. However, challenges such as data analysis, storage, and interpretation remain, requiring the development of robust bioinformatics tools and computational techniques to fully harness the potential of NGS in various scientific fields.

Japan Next-Generation Sequencing Market Trends:

The next-generation sequencing market in Japan is experiencing rapid growth, largely fueled by several key factors. Firstly, the increasing prevalence of chronic diseases regionally has heightened the demand for advanced diagnostic tools, propelling the adoption of NGS technologies. Consequently, healthcare providers are increasingly integrating NGS into their clinical practices, aiming to offer personalized treatments and enhance patient outcomes. Moreover, the plummeting costs associated with genome sequencing have significantly broadened the accessibility of NGS platforms, thereby encouraging their widespread utilization across research and clinical settings. Additionally, the escalating focus on precision medicine and the rising significance of genomics in drug discovery and development has bolstered the demand for NGS, fostering collaborations between biotechnology firms and research institutions to expedite the translation of genomic insights into targeted therapies. Furthermore, the continual advancements in bioinformatics tools and data analysis techniques, which have facilitated the interpretation of complex genomic data, thereby stimulating the adoption of NGS technologies in various fields, are expected to drive the NGS market in Japan during the forecast period.

Japan Next-Generation Sequencing Market Segmentation:

Sequencing Type Insights:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others

Product Type Insights:

  • Instruments
  • Reagents and Consumables
  • Software and Services

Technology Insights:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

Application Insights:

  • Biomarker and Cancer
  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others

End User Insights:

  • Academic Institutes and Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan next-generation sequencing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan next-generation sequencing market?
  • What is the breakup of the Japan next-generation sequencing market on the basis of sequencing type?
  • What is the breakup of the Japan next-generation sequencing market on the basis of product type?
  • What is the breakup of the Japan next-generation sequencing market on the basis of technology?
  • What is the breakup of the Japan next-generation sequencing market on the basis of application?
  • What is the breakup of the Japan next-generation sequencing market on the basis of end user?
  • What are the various stages in the value chain of the Japan next-generation sequencing market?
  • What are the key driving factors and challenges in the Japan next-generation sequencing?
  • What is the structure of the Japan next-generation sequencing market and who are the key players?
  • What is the degree of competition in the Japan next-generation sequencing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Next-Generation Sequencing Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Next-Generation Sequencing Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Next-Generation Sequencing Market - Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Targeted Resequencing
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 RNA Sequencing
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 CHIP Sequencing
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 De Novo Sequencing
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Methyl Sequencing
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2019-2024)
    • 6.7.3 Market Forecast (2025-2033)
  • 6.8 Others
    • 6.8.1 Historical and Current Market Trends (2019-2024)
    • 6.8.2 Market Forecast (2025-2033)

7 Japan Next-Generation Sequencing Market - Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Reagents and Consumables
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Software and Services
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Next-Generation Sequencing Market - Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Nanopore Sequencing
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2019-2024)
    • 8.5.2 Market Forecast (2025-2033)

9 Japan Next-Generation Sequencing Market - Breakup by Application

  • 9.1 Biomarker and Cancer
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Drug Discovery and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Genetic Screening
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Agriculture and Animal Research
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Others
    • 9.6.1 Historical and Current Market Trends (2019-2024)
    • 9.6.2 Market Forecast (2025-2033)

10 Japan Next-Generation Sequencing Market - Breakup by End User

  • 10.1 Academic Institutes and Research Centers
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Hospitals and Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2019-2024)
    • 10.4.2 Market Forecast (2025-2033)

11 Japan Next-Generation Sequencing Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Services Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Services Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Services Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Services Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Services Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Next-Generation Sequencing Market - Industry Analysis

  • 13.1 Drivers, Restraints and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix